alexandria semaglutide & tirzepatide πβ¨Meet Tirzepatide: The Dual-Action Hero! This innovative medication works A new advancement in diabetes
Description
Oral semaglutide is being developed as a co-formulation with the absorption enhancer sodium N -(8-[2-hydroxybenzoyl] amino) caprylate (SNAC)
You're never alone
To view or add a comment, sign in New Clinical Trial: Intra-abdominal Pressure (IAP) During PFA Treatment of A-fib/ A-Flutter Intra-Abdominal Hypertension | Phase: N/A | Sponsor: Wake Forest University Health Sciences | The purpose of this study is to investigate the intra-abdominal pressure utilizing the Accuryn monitoring system during pulsed field ablation procedures in the electrophysiology lab compared to the ty #clinicaltrials #healthcare #research #clinicalmetric To view or add a comment, sign in Ahead of Lp(a) Awareness Day , there was a great discussion published in the journal of clinical lipidology, about Lp(a) JCL roundtable: European perspective on comprehensive lipid management and cardiovascular health Lp(a) is a genetic risk factor that should be tested for in all adults, and used to inform overall risk assessment and treatment intensity

GLP-1 drugs can reduce total body fat, but the seen shape might not significantly shift
